- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05032677
Dural Puncture Epidural Technique Versus Conventional Epidural Techmique
December 13, 2022 updated by: Reham Ali Abdelhaleem Abdelrahman, Cairo University
Comparative Study Between Dural Puncture Epidural Technique Versus Conventional Epidural Technique During Laparoscopic Hysterectomy
This study will be conducted on 50 patients of ASA grade I and II aged from 25 to 55 years and presented for laparoscopic hysterectomy.
Patients will be divided into two equal groups; group A control group for conventional epidural technique(n=25) and group B for 25G dural puncture epidural with 25G pencil point Whitacre spinal needle (n=25).
Randomization will be done using computer generated number and concealed using sequentially numbered, sealed opaque envelope.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt, 11562
- Department of Anesthesia, Surgical ICU, and Pain Management
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 51 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- ASA I and II
- Height(150-170 cm)
Exclusion Criteria:
- patient refusal
- hypersensitivity to local anesthetic drugs
- bleeding disorders and coagulopathy(platelets count less than 80000,INR less than 1.5 or therapeutic dose of anticoagulant).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Conventional Epidural Technique
|
25G Dural Puncture Epidural Block at L2-3 inter-space then bupivacaine 0.5% 15-20 ml with 50ug fentanyl was given.
|
|
Active Comparator: Dural Puncture Epidural technique using pencil-point 25G Whitacre needle
|
Standard Lumbar Epidural Block using Touhy Epidural Needle (18G) at L2-3 inter-space and Epidural Catheter (20G) was inserted then bupivacaine 0.5% 15-20 ml with 50ug fentanyl was given.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
incidence of bilateral sacral blockade
Time Frame: Up to 30 minutes after local anesthetic injection
|
Sensory blockade was evaluated using a non-traumatic pinprick stimulus starting at the S2 dermatome and moving in a caudad direction (measured every 2 minutes)
|
Up to 30 minutes after local anesthetic injection
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Reham Ali Abdelrahman, M.D., Cairo University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 18, 2021
Primary Completion (Actual)
November 2, 2022
Study Completion (Actual)
December 10, 2022
Study Registration Dates
First Submitted
August 27, 2021
First Submitted That Met QC Criteria
August 27, 2021
First Posted (Actual)
September 2, 2021
Study Record Updates
Last Update Posted (Estimate)
December 15, 2022
Last Update Submitted That Met QC Criteria
December 13, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- ES-2022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gynecologic Disease Requiring Laparoscopic Hysterectomy Under Neuraxial Anesthesia
-
Cairo UniversityCompletedGynecologic Disease Requiring Vaginal Operation Under Neuraxial AnesthesiaEgypt
-
Balikesir UniversityCompletedLaparoscopic Hysterectomy | ASA Class I/II Patients Scheduled for Surgery Under General AnesthesiaTurkey (Türkiye)
-
Azienda Socio Sanitaria Territoriale degli Spedali...CompletedGynecologic Cancer | Surgery | Anesthesia | Hysterectomy | Gynecologic DiseaseItaly
-
Cairo UniversityCompletedGynecologic Diseases Requiring Vaginal HysterectomyEgypt
Clinical Trials on Dural Puncture Epidural Technique using pencil-point 25G Whitacre needle
-
Reham Ali Abdelhaleem AbdelrahmanCompleted
-
Cairo UniversityCompletedGynecologic Disease Requiring Vaginal Operation Under Neuraxial AnesthesiaEgypt
-
Cairo UniversityCompletedGynecologic Diseases Requiring Vaginal HysterectomyEgypt